The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) is deeply committed to continuing global progress toward controlling the HIV epidemic – country by country, community by community. As we join the world in confronting the unique challenges posed by the novel coronavirus (COVID-19), we are dedicated to doing what is needed to serve, support, and protect our clients, communities, staff, and partners around the world.
Access the COVID-19 resource portal for information on the virus, symptoms, and preventative tips. It contains the latest statistics on COVID-19 in South Africa, as well as press releases on the country's response.
UNAIDS Executive Director Winnie Byanyima shares that there is currently no strong evidence that people living with HIV are at an especially increased risk of contracting COVID-19 or, that if they do contract it, they will experience a worse outcome. People living with HIV should take all recommended preventive measures to minimize exposure and prevent infection, and all countries should ensure that medication is available.
Sofia Bandomia and her team in Portuguese-speaking Mozambique had long found it challenging to enroll men living with HIV in care and treatment. What she found 5,000 miles, 11 countries and a language away in Cote d’Ivoire changed that.
Half of those attending HIV clinics in South Africa and Kenya were eligible to start HIV treatment after simple checks that could be performed by any healthcare worker, and same-day treatment initiation modestly improved the uptake of antiretroviral therapy (ART), results of a randomised trial pu
Programmes to scale-up HIV testing and treatment in countries in sub-Saharan Africa may have had less impact on new HIV infections than hoped, partly because they haven’t paid enough attention to groups that contribute disproportionately to HIV acquisition and transmission, experts say.
Scientists who announced the discovery of a new subtype of HIV earlier this month are telling people not to worry: The discovery, they say, is a good thing and shows that the technology used to make it will improve surveillance of the (admittedly, mutating) virus, but it doesn't mean that HIV wil